Screening for hypertrophic cardiomyopathy: a cost analysis of echocardiography, cardiac magnetic resonance and genetic testing
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1532-429X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Screening for hypertrophic cardiomyopathy: a cost analysis of echocardiography, cardiac magnetic resonance and genetic testing ; volume:11 ; number:1 ; day:28 ; month:1 ; year:2009 ; pages:1-316 ; date:1.2009
Journal of cardiovascular magnetic resonance ; 11, Heft 1 (28.1.2009), 1-316, 1.2009
- Creator
-
Hauser, Thomas H.
- Contributor
-
Maron, Martin S.
Manning, Warren J.
SpringerLink (Online service)
- DOI
-
10.1186/1532-429X-11-S1-O70
- URN
-
urn:nbn:de:1111-2016032157743
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hauser, Thomas H.
- Maron, Martin S.
- Manning, Warren J.
- SpringerLink (Online service)
Other Objects (12)
Journal of Cardiovascular Magnetic Resonance 2017
Journal of Cardiovascular Magnetic Resonance: 2017/2018 in review
Review of Journal of Cardiovascular Magnetic Resonance (JCMR) 2015-2016 and transition of the JCMR office to Boston
2048 The hypertrophic cardiomyopathy phenotype revisited with cardiovasculara magnetic resonance
2021–2022 state of our JCMR
2021 - State of our JCMR
2020 - State of our JCMR
2075 Papillary muscles and trabeculations significantly impact ventricular volume, ejection fraction, and regurgitation assessment by cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy
Diffuse fibrosis in dilated cardiomyopathy results in a shorter myocardial null time
2027 Accuracy and reproducibility of quantifying myocardial fibrosis in hypertrophic cardiomyopathy using delayed enhancement cardiovascular magnetic resonance thresholding techniques
2049 Improved detection of myocardial fibrosis using high-resolution, late gadolinium-enhanced cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy
Prognostic utility of late gadolinium enhancement cardiac magnetic resonance imaging in coronary artery disease: a meta-analysis
Journal of Cardiovascular Magnetic Resonance 2017
Journal of Cardiovascular Magnetic Resonance: 2017/2018 in review
Review of Journal of Cardiovascular Magnetic Resonance (JCMR) 2015-2016 and transition of the JCMR office to Boston
2048 The hypertrophic cardiomyopathy phenotype revisited with cardiovasculara magnetic resonance
2021–2022 state of our JCMR
2021 - State of our JCMR
2020 - State of our JCMR
2075 Papillary muscles and trabeculations significantly impact ventricular volume, ejection fraction, and regurgitation assessment by cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy
Diffuse fibrosis in dilated cardiomyopathy results in a shorter myocardial null time
2027 Accuracy and reproducibility of quantifying myocardial fibrosis in hypertrophic cardiomyopathy using delayed enhancement cardiovascular magnetic resonance thresholding techniques
2049 Improved detection of myocardial fibrosis using high-resolution, late gadolinium-enhanced cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy
Prognostic utility of late gadolinium enhancement cardiac magnetic resonance imaging in coronary artery disease: a meta-analysis
Journal of Cardiovascular Magnetic Resonance 2017
Journal of Cardiovascular Magnetic Resonance: 2017/2018 in review
Review of Journal of Cardiovascular Magnetic Resonance (JCMR) 2015-2016 and transition of the JCMR office to Boston
2048 The hypertrophic cardiomyopathy phenotype revisited with cardiovasculara magnetic resonance
2021–2022 state of our JCMR
2021 - State of our JCMR
2020 - State of our JCMR
2075 Papillary muscles and trabeculations significantly impact ventricular volume, ejection fraction, and regurgitation assessment by cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy
Diffuse fibrosis in dilated cardiomyopathy results in a shorter myocardial null time
2027 Accuracy and reproducibility of quantifying myocardial fibrosis in hypertrophic cardiomyopathy using delayed enhancement cardiovascular magnetic resonance thresholding techniques
2049 Improved detection of myocardial fibrosis using high-resolution, late gadolinium-enhanced cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy